These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 29509136)

  • 21. Antibiofilm peptides increase the susceptibility of carbapenemase-producing Klebsiella pneumoniae clinical isolates to β-lactam antibiotics.
    Ribeiro SM; de la Fuente-Núñez C; Baquir B; Faria-Junior C; Franco OL; Hancock RE
    Antimicrob Agents Chemother; 2015 Jul; 59(7):3906-12. PubMed ID: 25896694
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low prevalence of rmpA and high tendency of rmpA mutation correspond to low virulence of extended spectrum β-lactamase-producing Klebsiella pneumoniae isolates.
    Yu WL; Lee MF; Tang HJ; Chang MC; Chuang YC
    Virulence; 2015; 6(2):162-72. PubMed ID: 25830726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Investigation of various virulence factors of Klebsiella pneumoniae strains isolated from nosocomial infections].
    Kuş H; Arslan U; Türk Dağı H; Fındık D
    Mikrobiyol Bul; 2017 Oct; 51(4):329-339. PubMed ID: 29153063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Virulence genes, capsular and plasmid types of multidrug-resistant CTX-M(-2, -8, -15) and KPC-2-producing Klebsiella pneumoniae isolates from four major hospitals in Brazil.
    Andrade LN; Novais Â; Stegani LMM; Ferreira JC; Rodrigues C; Darini ALC; Peixe L
    Diagn Microbiol Infect Dis; 2018 Jun; 91(2):164-168. PubMed ID: 29459053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Determination and Correlation of Various Virulence Genes, ESBL, Serum Bactericidal Effect and Biofilm Formation of Clinical Isolated Classical Klebsiella pneumoniae and Hypervirulent Klebsiella pneumoniae from Respiratory Tract Infected Patients.
    Shah RK; Ni ZH; Sun XY; Wang GQ; Li F
    Pol J Microbiol; 2017 Dec; 66(4):501-508. PubMed ID: 29319515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of multidrug-resistant and virulent Klebsiella pneumoniae strains belonging to the high-risk clonal group 258 (CG258) isolated from inpatients in northeastern Brazil.
    Nakamura-Silva R; Oliveira-Silva M; Furlan JPR; Stehling EG; Miranda CES; Pitondo-Silva A
    Arch Microbiol; 2021 Sep; 203(7):4351-4359. PubMed ID: 34110479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo evolution of resistant subpopulations of KPC-producing Klebsiella pneumoniae during ceftazidime/avibactam treatment.
    Gaibani P; Campoli C; Lewis RE; Volpe SL; Scaltriti E; Giannella M; Pongolini S; Berlingeri A; Cristini F; Bartoletti M; Tedeschi S; Ambretti S
    J Antimicrob Chemother; 2018 Jun; 73(6):1525-1529. PubMed ID: 29566151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carbapenem-hydrolysing beta-lactamase KPC-2 in Klebsiella pneumoniae isolated in Rio de Janeiro, Brazil.
    Peirano G; Seki LM; Val Passos VL; Pinto MC; Guerra LR; Asensi MD
    J Antimicrob Chemother; 2009 Feb; 63(2):265-8. PubMed ID: 19028717
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emergence of New Non-Clonal Group 258 High-Risk Clones among Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae Isolates, France.
    Bonnin RA; Jousset AB; Chiarelli A; Emeraud C; Glaser P; Naas T; Dortet L
    Emerg Infect Dis; 2020 Jun; 26(6):1212-1220. PubMed ID: 32441629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clonal dissemination of KPC-2 producing Klebsiella pneumoniae ST11 clone with high prevalence of oqxAB and rmtB in a tertiary hospital in China: results from a 3-year period.
    Cheng L; Cao XL; Zhang ZF; Ning MZ; Xu XJ; Zhou W; Chen JH; Zhang JH; Shen H; Zhang K
    Ann Clin Microbiol Antimicrob; 2016 Jan; 15():1. PubMed ID: 26786830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. φBO1E, a newly discovered lytic bacteriophage targeting carbapenemase-producing Klebsiella pneumoniae of the pandemic Clonal Group 258 clade II lineage.
    D'Andrea MM; Marmo P; Henrici De Angelis L; Palmieri M; Ciacci N; Di Lallo G; Demattè E; Vannuccini E; Lupetti P; Rossolini GM; Thaller MC
    Sci Rep; 2017 Jun; 7(1):2614. PubMed ID: 28572684
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phenotypical and molecular assessment of the virulence potential of KPC-3-producing Klebsiella pneumoniae ST392 clinical isolates.
    D'Apolito D; Arena F; Conte V; De Angelis LH; Di Mento G; Carreca AP; Cuscino N; Russelli G; Iannolo G; Barbera F; Pasqua S; Monaco F; Cardinale F; Rossolini GM; Conaldi PG; Douradinha B
    Microbiol Res; 2020 Nov; 240():126551. PubMed ID: 32652494
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outbreak by Hypermucoviscous
    Zhan L; Wang S; Guo Y; Jin Y; Duan J; Hao Z; Lv J; Qi X; Hu L; Chen L; Kreiswirth BN; Zhang R; Pan J; Wang L; Yu F
    Front Cell Infect Microbiol; 2017; 7():182. PubMed ID: 28560183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emergence of KPC-2 and KPC-3 in carbapenem-resistant Klebsiella pneumoniae strains in an Israeli hospital.
    Leavitt A; Navon-Venezia S; Chmelnitsky I; Schwaber MJ; Carmeli Y
    Antimicrob Agents Chemother; 2007 Aug; 51(8):3026-9. PubMed ID: 17562800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiregional dissemination of KPC-producing Klebsiella pneumoniae ST258/ST512 genotypes in Poland, 2010-14.
    Baraniak A; Izdebski R; Zabicka D; Bojarska K; Górska S; Literacka E; Fiett J; Hryniewicz W; Gniadkowski M;
    J Antimicrob Chemother; 2017 Jun; 72(6):1610-1616. PubMed ID: 28333331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and validation of a multiplex PCR assay for identification of the epidemic ST-258/512 KPC-producing Klebsiella pneumoniae clone.
    Adler A; Khabra E; Chmelnitsky I; Giakkoupi P; Vatopoulos A; Mathers AJ; Yeh AJ; Sifri CD; De Angelis G; Tacconelli E; Villegas MV; Quinn J; Carmeli Y
    Diagn Microbiol Infect Dis; 2014 Jan; 78(1):12-5. PubMed ID: 24231383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coproduction of KPC-2 and QnrB19 in Klebsiella pneumoniae ST340 isolate in Brazil.
    Martins WM; Almeida AC; Nicoletti AG; Cayô R; Gales AC; Alves LC; Brayner FB; Vilela MA; Morais MM
    Diagn Microbiol Infect Dis; 2015 Dec; 83(4):375-6. PubMed ID: 26458280
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of Septic Shock Due to Multidrug-Resistant Acinetobacter baumannii or Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae in Intensive Care Unit Patients.
    Russo A; Giuliano S; Ceccarelli G; Alessandri F; Giordano A; Brunetti G; Venditti M
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29555630
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognosis of urinary tract infection caused by KPC-producing Klebsiella pneumoniae: The impact of inappropriate empirical treatment.
    Rodriguez-Gómez J; Pérez-Nadales E; Gutiérrez-Gutiérrez B; Machuca I; Martinez-Martinez L; Rivera F; Cano A; Castón JJ; Robles JC; de la Fuente C; Rodríguez-López F; Rodriguez-Baño J; Torre-Cisneros J;
    J Infect; 2019 Sep; 79(3):245-252. PubMed ID: 31276705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiology and outcome of
    Del Puente F; Giacobbe DR; Salsano A; Maraolo AE; Ong DSY; Yusuf E; Tutino S; Marchese A; Santini F; Viscoli C
    J Chemother; 2019; 31(7-8):359-366. PubMed ID: 31701842
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.